Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 0.86 | 1.36 |
NAV | ₹9.98 | ₹203.09 |
Fund Started | 03 Sep 2024 | 07 May 2007 |
Fund Size | ₹29.62 Cr | ₹89383.23 Cr |
Exit Load | Exit load of 0.25%, if redeemed within 15 days. | Exit load of 1% if redeemed within 1 year. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 3.11% | 6.79% |
3 Year | - | 24.51% |
5 Year | - | 26.22% |
1 Year
3 Year
5 Year
Equity | 99.95% | 93.94% |
Cash | 0.05% | 6.06% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
BSE Ltd. | 2.68% |
Hero Motocorp Ltd. | 1.91% |
Suzlon Energy Ltd. | 1.91% |
Persistent Systems Ltd. | 1.68% |
Dixon Technologies (India) Ltd. | 1.68% |
PB Fintech Ltd. | 1.60% |
Coforge Ltd. | 1.57% |
Cummins India Ltd. | 1.55% |
The Federal Bank Ltd. | 1.54% |
HDFC Asset Management Company Ltd. | 1.45% |
Name | Assets |
|---|---|
Max Financial Services Ltd. | 4.46% |
AU Small Finance Bank Ltd. | 3.70% |
Indian Bank | 3.54% |
The Federal Bank Ltd. | 3.38% |
Balkrishna Industries Ltd. | 3.37% |
Fortis Healthcare Ltd. | 3.19% |
Coforge Ltd. | 3.11% |
Hindustan Petroleum Corporation Ltd. | 2.96% |
Glenmark Pharmaceuticals Ltd. | 2.67% |
Ipca Laboratories Ltd. | 2.52% |
Name | Nemish Sheth | Chirag Setalvad |
Start Date | 13 Feb 2025 | 28 Jun 2014 |
Name
Start Date
Description | The scheme seeks to replicate the Nifty Midcap 150 Index by investing in securities of the Nifty Midcap 150 Index in the same proportion / weightage with an aim to provide returns before expenses that tracks the total return of Nifty Midcap 150 Index, subject to tracking errors. | The scheme seeks to provide long-term capital appreciation/income by investing predominantly in Mid-Cap companies. |
Launch Date | 03 Sep 2024 | 07 May 2007 |
Description
Launch Date